Largest biotech companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 20 biotech companies in the United States ranked by total assets, at DKK 616.5B, ahead of Gilead Sciences (DKK 401.7B) and Biogen (DKK 200.4B). Figures as of 20 Nov 2026, 14:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- AmgenDKK 616.5B
- Median
- DKK 16.6B
- Combined market value
- DKK 5T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | DKK 616.5B | DKK 1.62T | DKK 2,986.39 | 1.14% down | 30% up | ||
| 2 | Gilead SciencesGILD · Health Care | DKK 401.7B | DKK 1.41T | DKK 1,133.32 | 1.45% down | 31% up | ||
| 3 | BiogenBIIB · Health Care | DKK 200.4B | DKK 248.6B | DKK 1,681.84 | 1.70% down | 41% up | ||
| 4 | ModernaMRNA · Health Care | DKK 84B | DKK 548.9B | DKK 1,356.54 | 1.29% up | 740% up | ||
| 5 | Neurocrine BiosciencesNBIX · Health Care | DKK 31.5B | DKK 107.9B | DKK 1,065.67 | 3.85% down | 10% up | ||
| 6 | VaxcytePCVX · Health Care | DKK 20.4B | DKK 62.9B | DKK 397.17 | 0.27% down | 22% up | ||
| 7 | RepligenRGEN · Health Care | DKK 20.1B | DKK 74.1B | DKK 1,158.91 | 1.38% down | 5% up | ||
| 8 | ExelixisEXEL · Health Care | DKK 19.4B | DKK 109.3B | DKK 448.01 | 3.60% down | 55% up | ||
| 9 | Bio-TechneTECH · Health Care | DKK 17.6B | DKK 77.7B | DKK 494.76 | 0.07% down | 18% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | DKK 17.2B | DKK 72.2B | DKK 633.18 | 2.88% down | 32% up | ||
| 11 | Revolution MedicinesRVMD · Health Care | DKK 16B | DKK 234.7B | DKK 1,085.00 | 0.24% down | 125% up | ||
| 12 | Kymera TherapeuticsKYMR · Health Care | DKK 11.9B | DKK 69.4B | DKK 812.51 | 1.44% down | 81% up | ||
| 13 | Krystal BiotechKRYS · Health Care | DKK 9.1B | DKK 63.7B | DKK 2,149.31 | 0.15% up | 49% up | ||
| 14 | ImmunovantIMVT · Health Care | DKK 6.5B | DKK 45.8B | DKK 221.31 | 1.96% down | 44% up | ||
| 15 | CG OncologyCGON · Health Care | DKK 5.4B | DKK 49.8B | DKK 557.37 | 2.38% up | 93% up | ||
| 16 | Twist BioscienceTWST · Health Care | DKK 4.4B | DKK 51.8B | DKK 759.63 | 4.07% down | 291% up | ||
| 17 | Adaptive BiotechnologiesADPT · Health Care | DKK 3.5B | DKK 30.9B | DKK 190.89 | 1.44% down | 51% up | ||
| 18 | ImmunityBioIBRX · Health Care | DKK 3.4B | DKK 47.6B | DKK 44.71 | 1.94% down | 216% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | DKK 2.8B | DKK 41.8B | DKK 342.79 | 4.94% up | 25% up | ||
| 20 | Kodiak SciencesKOD · Health Care | DKK 2.4B | DKK 43.6B | DKK 666.26 | 0.09% up | 371% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8055 DKK).
Questions and answers
Which biotech companies in the United States rank first by total assets?
Amgen (DKK 616.5B), Gilead Sciences (DKK 401.7B) and Biogen (DKK 200.4B) are the top three of the 20 biotech companies in the United States ranked by total assets as of 20 Nov 2026, 14:27 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by total assets.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by total assets have a combined market value of DKK 5T as of 20 Nov 2026, 14:27 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.